Hipertrófiás kardiomiopátia: vizsgálatok itt: Németország
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in NémetországStudy of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
- Where
- Tübingen
- Életkor
- 6 év and over
- People
- 26 worldwide
- Run by
- Lexeo Therapeutics
See details and how to joinNCT07721025 · EU 2025-524970-40-00 - 2. fázisTaking peopleA randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
- Where
- Bad Oeynhausen, Goettingen, Heidelberg, Jena
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 - No phaseCsak meghívásosFocal Pulsed Field Ablation of Ventricular Tachycardia
- Where
- Wismar
- Életkor
- 18 év and over
- People
- 100
- Run by
- Sana Hanse Hospital Wismar
See details and how to joinNCT07929545 - 2. fázisTaking peopleA Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Where
- Bad Oeynhausen, Göttingen, Heidelberg, Jena
- Életkor
- 18 év and over
- People
- 165 worldwide
- Run by
- Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614 - 2/3. fázisTaking peopleOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- Bad Nauheim, Berlin, Essen, Goettingen, Heidelberg, Jena, Wuerzburg
- Életkor
- 18 év to 85 év
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00 - 2. fázisTaking peopleA Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Where
- Munich
- Életkor
- 8 év and over
- People
- 18 worldwide
- Run by
- Rocket Pharmaceuticals Inc.
See details and how to joinNCT06092034 - No phaseTaking peopleA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Aalen, Berlin, Bernau, Dresden, Erlangen, Leipzig, Münster
- Életkor
- 18 év and over
- People
- 1700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705 - No phaseTaking peopleRetrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)
- Where
- München
- People
- 100
- Run by
- Deutsches Herzzentrum Muenchen
See details and how to joinNCT07344480 - No phaseTaking peopleMultimodal Analysis of Endomyocardial Biopsies
- Where
- Essen
- Életkor
- 18 év and over
- People
- 216
- Run by
- University Hospital, Essen
See details and how to joinNCT07359690 - No phaseTaking peopleMavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy
- Where
- Munich
- Életkor
- 18 év to 99 év
- People
- 24
- Run by
- Technical University of Munich
See details and how to joinNCT07077005 - No phaseTaking peopleDZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
- Where
- Heidelberg
- Életkor
- 18 év to 80 év
- People
- 2040
- Run by
- University Hospital Heidelberg
See details and how to joinNCT04265040 - No phaseTaking peopleEvaluation of HEArt invoLvement in Patients With FABRY Disease
- Where
- Würzburg
- Életkor
- 18 év and over
- People
- 650
- Run by
- Wuerzburg University Hospital
See details and how to joinNCT03362164